Animal health biotechnology company developing ready-to-use, off-the-shelf stem cell therapies for dogs and cats
Animal health biotechnology company developing ready-to-use, off-the-shelf stem cell therapies for dogs and cats. Its regenerative medicine pipeline targets conditions including feline chronic gingivostomatitis, osteoarthritis, chronic kidney disease, and atopic dermatitis. Gallant also provides online continuing education for veterinary professionals through GallantU.